Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants.
Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. · 2023
Read Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. by Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10064807.txt.
Introduction
Cui and colleagues pool data from studies around the world to estimate how common vitamin D deficiency is, in a 2023 analysis. Low vitamin D weakens bones and is linked to many other health problems. The team gathered population studies from 2000 to 2022, covering millions of people in total.
Their pooled results give global and regional rates of low vitamin D. The analysis shows how rates vary by place, age, and the cutoff used to define low levels. The paper offers a baseline for health planners who track and tackle this quiet shortfall.
Catalog record
| CREATOR | Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants By Aiyong Cui, Tiansong Zhang, Peilong Xiao, Zhiqiang Fan, Hu Wang, Yan Zhuang Published in: Frontiers in Nutrition DOI: 10.3389/fnut.2023.1070808 ABSTRACT Background Vitamin D deficiency causes the bone hypomineralization disorder osteomalacia in humans and is associated with many non-skeletal disorders. We aim to estimate the global and regional prevalence of vitamin D deficiency in people aged 1 year or older from 2000 to 2022. Methods We systematically searched Web of Science, PubMed (MEDLINE), Embase, Scopus, and Google databases on December 31, 2021, and updated them on August 20, 2022, without language and time restrictions. Meanwhile, we identified references of relevant system reviews and eligible articles and included the latest and unpublished data from the National Health and Nutrition Examination Survey (NHANES, 2015–2016 and 2017–2018) database. The studies investigating the prevalence of vitamin D deficiency in population-based studies were included. A standardized data extraction form was used to collect information from eligible studies. We used a random-effects meta-analysis to estimate the global and regional prevalence of vitamin D deficiency. We stratified meta-analyses by latitude, season, six WHO regions, the World Bank income groups, gender, and age groups. This study was registered with PROSPERO (CRD42021292586). Findings Out of 67,340 records searched, 308 studies with 7,947,359 participants from 81 countries were eligible for this study, 202 (7,634,261 participants), 284 (1,475,339 participants), and 165 (561,978 participants) studies for the prevalence of serum 25(OH)D <30, <50, and <75 nmol/L, respectively. We found that globally, 15.7% (95% CrI 13.7–17.8), 47.9% (95% CrI 44.9–50.9), and 76·6% (95% CrI 74.0–79.1) of participants had serum 25-hydroxyvitamin D levels less than 30, 50, and 75 nmol/l, respectively; the prevalence slightly decreased from 2000–2010 to 2011–2022, but it was still at a high level; people living in high latitude areas had a higher prevalence; the prevalence in winter-spring was 1.7 (95% CrI 1.4–2.0) times that in summer-autumn; the Eastern Mediterranean region and Lower-middle-income countries had a higher prevalence; females were vulnerable to vitamin D deficiency; gender, sampling frame, detection assays, sampling region, time of data collection, season, and other factors contributed to heterogeneity between the included studies. Interpretation Globally, vitamin D deficiency remained prevalent from 2000 to 2022. The high prevalence of vitamin D deficiency would increase the global burden of disease. Therefore, governments, policymakers, health workers, and individuals should attach importance to the high prevalence of vitamin D deficiency and take its prevention as a public health priority. Systematic review registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021292586, PROSPERO CRD42021292586. INTRODUCTION Vitamin D, a fat-soluble prehormone, is essential to maintain calcium, phosphorus homeostasis, and others (1). Vitamin D deficiency has been considered a global health issue because it can cause the bone hypomineralization disorder osteomalacia in humans (2). Existing studies have reported that vitamin D deficiency is also associated with infectious diseases [severe coronavirus disease 2019 (COVID-19) and upper respiratory tract infection] (3–5). Many studies also reported the links between vitamin D deficiency and other diseases, for instance, muscle weakness, multiple sclerosis, diabetes, hypertension, metabolic syndrome, cancers, autoimmune diseases, cardiovascular disease, and hip or vertebrae fracture in later life (6–9). Vitamin D can be obtained from skin exposure to ultraviolet B radiation (UVB), dietary intake, and foods fortified with vitamin D. Studies show that the risk factors that are responsible for vitamin D deficiency include air pollution, latitude, season, the use of sunscreen, sedentary jobs, diet and others (10). The circulating concentration of total serum 25(OH)D was most often used to determine the status of vitamin D in the body. However, there are different consensus recommendations on the cut-off definition of vitamin D deficiency. In consideration of the risk of metabolic bone disease, the US Institute of Medicine (IOM) agreed that the value of serum 25(OH)D <30 nmol/L (12 ng/mL) is considered as vitamin D deficiency, 30–50 nmol/L (12–20 ng/mL) is considered as vitamin D insufficiency, and ≥50 nmol/L (20 ng/mL) is considered as being sufficient (11). In the light of increasing levels of circulating parathyroid hormone the Endocrine Society designated the threshold of vitamin D deficiency at ≤ 50 nmol/L (20 ng/mL), the threshold of vitamin D insufficiency at 50–75 nmol/L (20–30 ng/mL), the threshold of vitamin D normal at ≥75 nmol/L (30 ng/mL) (12, 13). Nevertheless, all guidelines have reached the consensus that the value of serum 25(OH)D <25 or 30 nmol/l (10–12 ng/ml) should be averted at all ages (14). Some previous systematic reviews and meta-analyses have investigated the mean value of serum 25(OH)D in the population worldwide from 1990 to 2011 and the prevalence of vitamin D deficiency in Europe, Africa, and Asia (15–21). In recent years, new studies examining the prevalence of vitamin D deficiency have dramatically increased in each country all over the world. However, there is still no study estimating the global and regional prevalence of vitamin D deficiency. In addition, it is time-consuming, laborious, and expensive to carry out a representative large-scale study on the global population. Therefore, we pooled published data to investigate the global and regional prevalence of vitamin D deficiency in the general population from 2000 to 2022. METHODS This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline (22, 23). The protocol of the study was preregistered in the PROSPERO database (CRD42021292586). Search and select strategy To comprehensively describe the global and regional prevalence of vitamin D deficiency, AC and PX, under the guidance of the doctor (TZ) of clinical evidence-based medicine, systematically searched Web of Science, PubMed (MEDLINE), Embase, Scopus, and Google databases. The databases were searched on December 31, 2021, and updated them on August 20, 2022, without language and time restrictions. The details of the retrieval strategy are uploaded in Appendix 1 (Supplementary Tables 1–4). We also tried to retrieve relevant gray articles Google database, but no eligible articles were found. Additionally, we manually searched references of relevant system reviews and eligible articles. Furthermore, we included the latest and unpublished data from the National Health and Nutrition Examination Survey (NHANES, 20015–2016 and 20017–2018) database, (24) which was a nationally representative nutrition survey in the United States. In order to identify eligible studies, firstly, we used endnote to remove duplicates. Then according to inclusion and exclusion criteria, AC and PX scanned the title and abstract independently. Finally, AC and PX browsed the full text of the remaining articles. All inconsistencies encountered in the selection of studies were resolved through consensus reached by all authors. Inclusion and exclusion criteria Inclusion and exclusion criteria were developed with reference to related published research (17, 18, 25, 26). The aim of our study is to assess the global and regional prevalence of vitamin D deficiency in population aged 1 year or older from 2000 to 2022. Therefore, we included studies reporting the prevalence of vitamin D deficiency in population aged 1 year or older, studies collecting data after 2000, and studies including a sample size of more than 50 (aiming to avoid biases caused by small samples). In articles that used the same data source, only the study with the richest data was included. The